Solar urticaria induced by visible light: successful treatment with omalizumab.
Clin Exp Dermatol
; 41(8): 890-892, 2016 Dec.
Article
in En
| MEDLINE
| ID: mdl-27766671
ABSTRACT
We report the case of a 53-year-old man with solar urticaria (SU) not responding to histamine antagonist therapy. Using intradermal testing with the patient's irradiated serum, we demonstrated that his SU was elicited by visible light only. This type of SU is uncommon, and makes preventive measures such as sun block largely ineffective. However, the patient had an extraordinary response to the treatment with omalizumab. This case report highlights the diagnostic process and the success of omalizumab for the treatment of SU after 16 months of follow-up.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Photosensitivity Disorders
/
Sunlight
/
Urticaria
/
Anti-Allergic Agents
/
Omalizumab
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Exp Dermatol
Year:
2016
Document type:
Article
Affiliation country:
Suiza